These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1997652)
21. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Hart PH; Vitti GF; Burgess DR; Whitty GA; Piccoli DS; Hamilton JA Proc Natl Acad Sci U S A; 1989 May; 86(10):3803-7. PubMed ID: 2786204 [TBL] [Abstract][Full Text] [Related]
22. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Sebbag M; Parry SL; Brennan FM; Feldmann M Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801 [TBL] [Abstract][Full Text] [Related]
23. Suppression of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and granulocyte-monocyte colony stimulating factor secretion from human monocytes by an extract of Poria cocos. Tseng J; Chang JG Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):1-11. PubMed ID: 1306145 [TBL] [Abstract][Full Text] [Related]
24. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes. Joyce DA; Steer JH Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066 [TBL] [Abstract][Full Text] [Related]
25. 17beta-estradiol and progesterone do not influence the production of cytokines from lipopolysaccharide-stimulated monocytes in humans. Bouman A; Schipper M; Heineman MJ; Faas M Fertil Steril; 2004 Oct; 82 Suppl 3():1212-9. PubMed ID: 15474098 [TBL] [Abstract][Full Text] [Related]
26. Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis. Terao I; Hashimoto S; Horie T Int Arch Allergy Immunol; 1993; 102(3):242-8. PubMed ID: 8219777 [TBL] [Abstract][Full Text] [Related]
27. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139 [TBL] [Abstract][Full Text] [Related]
28. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Iino Y; Toriyama M; Kudo K; Natori Y; Yuo A Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():16-20. PubMed ID: 1416647 [TBL] [Abstract][Full Text] [Related]
29. KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line. Sugimoto M; Inoue T; Yamashita M; Takeshita K; Nakaike S Drugs Exp Clin Res; 2002; 28(5):197-205. PubMed ID: 12635495 [TBL] [Abstract][Full Text] [Related]
30. Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures. Dimri R; Nissimov L; Keisari Y Lymphokine Cytokine Res; 1994 Aug; 13(4):239-45. PubMed ID: 7528061 [TBL] [Abstract][Full Text] [Related]
31. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. Ghazali A; Fuentès V; Desaint C; Bataille P; Westeel A; Brazier M; Prin L; Fournier A J Clin Endocrinol Metab; 1997 Jan; 82(1):32-8. PubMed ID: 8989228 [TBL] [Abstract][Full Text] [Related]
32. Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. Taupin V; Gogusev J; Descamps-Latscha B; Zavala F Mol Pharmacol; 1993 Jan; 43(1):64-9. PubMed ID: 8380885 [TBL] [Abstract][Full Text] [Related]
33. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes. Couturier C; Jahns G; Kazatchkine MD; Haeffner-Cavaillon N Eur J Immunol; 1992 Jun; 22(6):1461-6. PubMed ID: 1376258 [TBL] [Abstract][Full Text] [Related]
35. Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid. Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM Br J Cancer; 1999 May; 80(5-6):716-23. PubMed ID: 10360649 [TBL] [Abstract][Full Text] [Related]
36. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Makonkawkeyoon S; Limson-Pobre RN; Moreira AL; Schauf V; Kaplan G Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5974-8. PubMed ID: 8327469 [TBL] [Abstract][Full Text] [Related]
37. Tolerance to endotoxin in vitro: independent regulation of interleukin-1, tumor necrosis factor and interferon alpha production during in vitro differentiation of human monocytes. Lepe-Zuniga JL; Klostergaard J Lymphokine Res; 1990; 9(3):309-19. PubMed ID: 2204768 [TBL] [Abstract][Full Text] [Related]